Vimarsana
Biggest News Aggregation in the World

Page 8 - Clinical Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Diagnostics Today - Breaking & Trending Today

Mutual of America Capital Management LLC Has $1.05 Million Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Vimarsana News

Mutual of America Capital Management LLC Has $1.05 Million Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)

Mutual of America Capital Management LLC cut its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 4.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,921 shares of the medical research company’s stock after selling 148 shares during the […]

Latest IVDR extension: What does it mean for you? on SelectScience - Vimarsana News

Latest IVDR extension: What does it mean for you? on SelectScience

Watch the latest scientific webinars on SelectScience.

Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Purchased by Grantham Mayo Van Otterloo & Co. LLC - Vimarsana News

Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Purchased by Grantham Mayo Van Otterloo & Co. LLC

Grantham Mayo Van Otterloo & Co. LLC raised its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 6.9% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 82,443 shares of the medical research company’s stock after purchasing an additional 5,339 shares during the […]

Bio-Rad Laboratories (NYSE:BIO) Releases Earnings Results, Beats Estimates By $0.17 EPS - Vimarsana News

Bio-Rad Laboratories (NYSE:BIO) Releases Earnings Results, Beats Estimates By $0.17 EPS

Bio-Rad Laboratories (NYSE:BIO – Get Free Report) posted its earnings results on Thursday. The medical research company reported $3.10 EPS for the quarter, topping analysts’ consensus estimates of $2.93 by $0.17, Briefing.com reports. The company had revenue of $681.18 million for the quarter, compared to the consensus estimate of $685.00 million. Bio-Rad Laboratories had a […]

Bio-Rad Laboratories, Inc. (NYSE:BIO) Q4 2023 Earnings Call Transcript - Vimarsana News

Bio-Rad Laboratories, Inc. (NYSE:BIO) Q4 2023 Earnings Call Transcript

Bio-Rad Laboratories, Inc. (NYSE:BIO) Q4 2023 Earnings Call Transcript February 15, 2024 Bio-Rad Laboratories, Inc. beats earnings expectations. Reported EPS is $3.1, expectations were $2.93. BIO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen. And […]

Source: yahoo.com